CLASS I ONGOING Drug recall · Reported 19 Aug 2026 · FDA Enforcement Report

Optiray Imaging -350, Ioversol Injection recalled

Liebel-Flarsheim is recalling Optiray Imaging -350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, distributed nationwide in the US. The recall was initiated on 31 Jul 2026 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot # 25ZF3670, Exp Date: May 31, 2027.
NDC0019-1323, 0019-1333, 0019-1332
UPC0300191332653, 0300191323651, 0300191333650
Quantity recalled3,486 500mL-vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0773-2026
FDA event ID
99510
Recalling firm
Liebel-Flarsheim, Raleigh, NC
Brand
Optiray
Manufacturer
Liebel-Flarsheim Company LLC
Classification
Class I
Status
Ongoing
Recall initiated
31 Jul 2026
FDA classified
19 Aug 2026
Reported
19 Aug 2026
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Particulate Matter

Timeline

31 Jul 2026Recall initiated by company
19 Aug 2026Classified by FDA+19 days
19 Aug 2026Published in enforcement report+0 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.

Product as listed by the FDA

Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, 500 mL Multiple-Dose Vial, Rx only, Sterile Solution, Manufactured by: Liebel-Flarsheim Company LLC, Raleigh, NC 27616, Made in USA, NDC 0019-1333-65.

Where it was distributed

Distributed Nationwide in the US and Mexico.

Nationwide

Questions about this recall

Why was it recalled?

Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.

Which lots are affected?

Lot # 25ZF3670, Exp Date: May 31, 2027.

Where was it sold?

Distributed Nationwide in the US and Mexico.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Liebel-Flarsheim

All 4

Other Ioversol recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIOptiray 320 (ioversol) Injection recalled by GuerbetOptirayGuerbetPackaging DefectsNationwide